The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors.
Castelletti D, Fiaschetti G, Di Dato V, Ziegler U, Kumps C, De Preter K, Zollo M, Speleman F, Shalaby T, De Martino D, Berg T, Eggert A, Arcaro A, Grotzer MA.
Castelletti D, et al. Among authors: shalaby t.
Mol Cancer Ther. 2010 Dec;9(12):3145-57. doi: 10.1158/1535-7163.MCT-10-0539. Epub 2010 Oct 1.
Mol Cancer Ther. 2010.
PMID: 20889731
Free article.